AI assistant
Sending…
NOVAVAX INC — Director's Dealing 2013
Mar 6, 2013
31982_dirs_2013-03-06_c55b1538-cc62-41c0-a43e-30070151a5bb.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: NOVAVAX INC (NVAX)
CIK: 0001000694
Period of Report: 2013-03-02
Reporting Person: Erck Stanley C (Director, President and CEO)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2013-03-02 | Options-right to buy | $1.83 | A | 900000 | Acquired | 2023-03-02 | Common Stock (900000) | Direct |
Footnotes
F1: Options shall vest in four equal annual installments beginning on the first anniversary of the date of grant.